Alvogen
PrivateLast Round
Debt
3/7/2022
Total Funding Raised
$769M
Momentum Score
25 /100
Company Overview
Alvogen Group is a pharmaceutical company that specializes in developing both generic and branded specialty products aimed at promoting long, healthy, and active lives through affordable medications for various medical conditions, including oncology, cardiology, respiratory, neurology, and gastroenterology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alvogen Comps
Public and private peers based on sector, stage, and business model.
Alvogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | 3/7/2022 | ||||
| Private Equity | 6/30/2021 | ||||
| Buyout/LBO | 6/22/2015 | ||||
| Buyout/LBO | 4/2/2014 | ||||
| Private Placement | 11/19/2010 |
Key People
Founding team and executive leadership
Alvogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Buyout/LBO |
| Vatera Healthcare Partners | Buyout/LBO |
| Pamplona Capital Management | Buyout/LBO |
| CVC Capital Partners | Buyout/LBO |
| Morgan Stanley | Private Equity |
| Centerbridge Partners | Debt |
| Blue Torch Capital | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Developing SLX-100 for spinocerebellar ataxia in partnership with Solaxa.
- Feb 23, 2026
Partnered with Solaxa to co-develop SLX-100 for spinocerebellar ataxia.
Alvogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alvogen's valuation, stock price, and market status.
